SCHEMBL30674331

SCHEMBL30674331

Cc1ccc(S(=O)(=O)n2cc(-c3ccccc3)c3c(Br)ccnc32)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.53
LMNA P02545 3/20 0.46
MAPT P10636 2/20 0.46
ALDH1A1 P00352 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HTT P42858 2/20 0.41
POLB P06746 1/20 0.41
ALDH3A1 P30838 1/20 0.41
NOD1 Q9Y239 1/20 0.41
CA2 P00918 3/20 0.41
CA1 P00915 2/20 0.41
HTR6 P50406 2/20 0.40
NR1H2 P55055 1/20 0.40
NR1H3 Q13133 1/20 0.40
CCNA2 P20248 1/20 0.40
CDK2 P24941 1/20 0.40
CA12 O43570 2/20 0.40
CA9 Q16790 2/20 0.40
MCOLN3 Q8TDD5 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26930421 1.00 L3MBTL1 (0.53) L3MBTL1LMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL8241397 0.92 HTR6 (0.48) L3MBTL1LMNAMAPTCA2CA1
SCHEMBL25238794 0.84 CA1 (0.50) L3MBTL1ALDH1A1HTTPOLBALDH3A1
SCHEMBL20437149 0.83 L3MBTL1 (0.48) L3MBTL1HTTPOLBALDH3A1NOD1
SCHEMBL26930315 0.81 L3MBTL1 (0.46) L3MBTL1LMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL30674367 0.81 L3MBTL1 (0.46) L3MBTL1LMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL8944259 0.80 L3MBTL1 (0.67) L3MBTL1LMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL20210703 0.79 L3MBTL1 (0.53) L3MBTL1LMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL30674333 0.79 L3MBTL1 (0.46) L3MBTL1LMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL26930313 0.79 L3MBTL1 (0.46) L3MBTL1LMNAMAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4536657-A1 LATS INHIBITORS AND USES THEREOF The USA, as represented by The Secretary, Department of Health and Human Services (US) 2025-04-16 EP disclosed
WO-2023239727-A1 LATS INHIBITORS AND USES THEREOF THE USA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) 2023-12-14 WO disclosed